文献速递甲状腺疾病

母体甲状腺功能与妊娠期高胆汁酸血症的关联

Association of Maternal Thyroid Function with Gestational Hypercholanemia.
PubMed 文献 · Thyroid · 2021-12-23

基于68,016例单胎妊娠前瞻性队列,早孕期或晚孕期游离甲状腺素(fT4)升高均与总胆汁酸(TBA)浓度升高及高胆汁酸血症风险升高相关(均p<0.01)。晚孕期临床甲状腺功能亢进症与高胆汁酸血症风险升高2.12倍相关(CI 1.12-4.03,p=0.021),亚临床甲状腺功能亢进症与风险升高1.5倍相关(CI 1.14-1.97,p=0.0034)。促甲状腺激素(TSH)与高胆汁酸血症无关联。

要点

  • 早孕期或晚孕期fT4升高均与TBA升高及高胆汁酸血症风险升高相关。
  • 晚孕期临床甲亢与高胆汁酸血症风险升高2.12倍相关(CI 1.12-4.03)。
  • 晚孕期亚临床甲亢与高胆汁酸血症风险升高1.5倍相关(CI 1.14-1.97)。

核心结论

  • 早孕期或晚孕期fT4升高而非TSH浓度与TBA升高及妊娠期高胆汁酸血症风险升高相关。
  • 妊娠期甲状腺功能亢进症可能是高胆汁酸血症的新危险因素。

研究设计与样本

  • 基于前瞻性队列纳入68,016例单胎妊娠,孕前无已知甲状腺或肝胆疾病且未使用甲状腺药物。
  • 早孕期(9-13周)和晚孕期(32-36周)常规筛查甲状腺功能及血清总胆汁酸(TBA)。
  • 高胆汁酸血症定义为血清TBA浓度≥10 μmol/L。
  • 采用多元线性回归模型和多元逻辑回归模型进行分析。

主要发现

  • 早孕期或晚孕期fT4较高均与TBA浓度较高及高胆汁酸血症风险较高相关(均p<0.01)。
  • 早孕期TSH较高与早孕期TBA浓度较高相关(p=0.0155),但与晚孕期TBA浓度较低相关(p<0.0001),TSH与高胆汁酸血症无关联。
  • 晚孕期临床甲状腺功能亢进症与高胆汁酸血症风险升高2.12倍相关(CI 1.12-4.03,p=0.021)。
  • 晚孕期亚临床甲状腺功能亢进症与高胆汁酸血症风险升高1.5倍相关(CI 1.14-1.97,p=0.0034)。
  • 敏感性分析提示整个孕期fT4较高与高胆汁酸血症风险较高相关,而非仅限于早孕期或晚孕期。

关键数值与推荐

  • 高胆汁酸血症定义为血清TBA浓度≥10 μmol/L。
  • 晚孕期临床甲状腺功能亢进症与高胆汁酸血症风险升高2.12倍相关(CI 1.12-4.03,p=0.021)。
  • 晚孕期亚临床甲状腺功能亢进症与高胆汁酸血症风险升高1.5倍相关(CI 1.14-1.97,p=0.0034)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: High bile acid concentration is associated with adverse perinatal outcomes (i.e., stillbirth and preterm birth) and experimental studies indicate that thyroid hormone regulates bile acid metabolism, but this has not yet been translated to clinical data in pregnant women. We aim to explore the association of thyroid function with bile acid concentrations and the risk of gestational hypercholanemia. Methods: This study comprised 68,016 singleton pregnancies without known thyroid or hepatobiliary diseases before pregnancy and thyroid medication based on a prospective cohort. Thyroid function and serum total bile acid (TBA) were routinely screened in both early (9-13 weeks) and late pregnancy (32-36 weeks). Hypercholanemia was defined as serum TBA concentration ≥10 μmol/L. Multiple linear regression models and multiple logistic regression models were performed. Results: A higher free thyroxine (fT4) during both early or late pregnancy was associated with a higher TBA concentration and a higher risk of hypercholanemia (all p < 0.01). A higher thyrotropin (TSH) in early pregnancy was associated with a higher TBA concentration in early pregnancy (p = 0.0155), but with a lower TBA concentration during later pregnancy (p < 0.0001), and there was no association of TSH with hypercholanemia. Overt hyperthyroidism in late pregnancy was associated with a 2.12-fold higher risk of hypercholanemia ([confidence interval; CI 1.12-4.03], p = 0.021) and subclinical hyperthyroidism during later pregnancy was associated with a 1.5-fold higher risk of hypercholanemia ([CI 1.14-1.97], p = 0.0034). Sensitivity analyses indicated that a high fT4 throughout pregnancy was associated with a higher risk of hypercholanemia rather than only in early or late pregnancy. Conclusions: A higher fT4 concentration during either early or late pregnancy, but not the TSH concentration, is associated with higher TBA and a higher risk of gestational hypercholanemia. Furthermore, hyperthyroidism during pregnancy could be a novel risk factor for hypercholanemia.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Yang X, Zhang C, Williamson C, et al. Association of Maternal Thyroid Function with Gestational Hypercholanemia. Thyroid. 2021. PMID: 34941431. doi:10.1089/thy.2021.0242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。